Gilead is committed to helping improve the lives of people around the world by bringing forward medicines that prevent, treat and cure devastating diseases. We currently offer more than 25 therapies in the United States and are rapidly growing our portfolio through internal research and development, as well as collaborations with academic and industry partners.

The content on this page is not intended for users outside the United States.